Risk assessment of thromboembolic events in hospitalized cancer patients

Hospitalized cancer patients are at increased risk for Thromboembolic Events (TEs). As untailored thromboprophylaxis is associated with hemorrhagic complications, the definition of a risk-assessment model (RAM) in this population is needed. INDICATE was a prospective observational study enrolling ho...

Full description

Saved in:
Bibliographic Details
Main Authors: Nichetti, Federico (Author) , Ligorio, Francesca (Author) , Montelatici, Giulia (Author) , Porcu, Luca (Author) , Zattarin, Emma (Author) , Provenzano, Leonardo (Author) , Franza, Andrea (Author) , Lalli, Luca (Author) , de Braud, Filippo (Author) , Platania, Marco (Author)
Format: Article (Journal)
Language:English
Published: 14 September 2021
In: Scientific reports
Year: 2021, Volume: 11, Pages: 1-10
ISSN:2045-2322
DOI:10.1038/s41598-021-97659-9
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41598-021-97659-9
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41598-021-97659-9
Get full text
Author Notes:Federico Nichetti, Francesca Ligorio, Giulia Montelatici, Luca Porcu, Emma Zattarin, Leonardo Provenzano, Andrea Franza, Luca Lalli, Filippo de Braud & Marco Platania
Description
Summary:Hospitalized cancer patients are at increased risk for Thromboembolic Events (TEs). As untailored thromboprophylaxis is associated with hemorrhagic complications, the definition of a risk-assessment model (RAM) in this population is needed. INDICATE was a prospective observational study enrolling hospitalized cancer patients, with the primary objective of assessing the Negative Predictive Value (NPV) for TEs during hospitalization and within 45 days from discharge of low-grade Khorana Score (KS = 0). Secondary objectives were to assess KS Positive Predictive Value (PPV), the impact of TEs on survival and the development of a new RAM. Assuming 7% of TEs in KS = 0 patients as unsatisfactory percentage and 3% of as satisfactory, 149 patients were needed to detect the favorable NPV with one-sided α = 0.10 and power = 0.80. Stepwise logistic regression was adopted to identify variables included in a new RAM. Among 535 enrolled patients, 153 (28.6%) had a KS = 0. The primary study objective was met: 29 (5.4%) TEs were diagnosed, with 7 (4.6%) cases in the KS = 0 group (NPV = 95.4%, 95% CI 90.8-98.1%; one-sided p = 0.084). However, the PPV was low (5.7%, 95% CI 1.9-12.8%); a new RAM based on albumin (OR 0.34, p = 0.003), log(LDH) (OR 1.89, p = 0.023) and presence of vascular compression (OR 5.32, p < 0.001) was developed and internally validated. Also, TEs were associated with poorer OS (median, 5.7 vs 24.8 months, p < 0.001). INDICATE showed that the KS has a good NPV but poor PPV for TEs in hospitalized cancer patients. A new RAM was developed, and deserves further assessment in external cohorts.
Item Description:Gesehen am 11.11.2021
Physical Description:Online Resource
ISSN:2045-2322
DOI:10.1038/s41598-021-97659-9